Nicotinic acetylcholine receptor

Nicotinic acetylcholine receptor
Harbin · Public domain · source
Name	Nicotinic acetylcholine receptor
Family	Ligand-gated ion channel
Function	Ionotropic neurotransmission

Nicotinic acetylcholine receptor Nicotinic acetylcholine receptor is an ionotropic receptor that mediates fast synaptic transmission in vertebrate and invertebrate nervous systems. It has been studied across fields including molecular biology, neurophysiology, pharmacology, and clinical medicine, and has been a focal point for research at institutions such as National Institutes of Health, Howard Hughes Medical Institute, and Max Planck Society. Landmark discoveries involving this receptor intersect with work by researchers connected to University of Cambridge, Harvard University, Massachusetts Institute of Technology, and Stanford University.

Structure and Subunit Composition

The receptor is a pentameric assembly composed of homologous subunits encoded by multigene families such as CHRNA and CHRNB, with classic subtypes described by combinations of α, β, γ, δ, and ε subunits revealed in studies from Cold Spring Harbor Laboratory, Institute Pasteur, and Salk Institute. Cryo-electron microscopy and X-ray crystallography efforts led by teams at European Molecular Biology Laboratory, Max Planck Institute of Biophysics, and University of Oxford have resolved extracellular ligand-binding domains and transmembrane pore architectures akin to those reported for other Cys-loop receptors studied at Weizmann Institute of Science. Structural motifs such as the signature "Cys-loop" were first contextualized in work associated with University of California, San Francisco and later refined by collaborations involving Johns Hopkins University and Columbia University. Conserved residues in the M2 transmembrane helix, characterized using site-directed mutagenesis in laboratories at Yale University and University of Pennsylvania, determine ion selectivity and conductance properties comparable to findings from Rockefeller University research on related ion channels.

Distribution and Localization

Subtypes exhibit distinct tissue distributions: muscle-type receptors predominate at neuromuscular junctions characterized in classic physiology texts from University College London and University of Edinburgh, while neuronal subtypes are abundant in central and peripheral nervous systems studied at National Institute of Mental Health and Karolinska Institute. Localization to synaptic versus extrasynaptic membranes was elucidated by imaging groups at Massachusetts General Hospital and University of California, Los Angeles, and trafficking mechanisms involve chaperones and assembly factors investigated at Duke University and Vanderbilt University. Developmental shifts in subunit expression have been observed in models studied at Princeton University and Brown University, with pathological redistributions reported in clinical series from Mayo Clinic and Cleveland Clinic.

Mechanism of Action

Ligand binding of acetylcholine or nicotine to orthosteric sites formed at subunit interfaces triggers conformational transitions from closed to open states, a process modeled computationally by groups at ETH Zurich and California Institute of Technology. Ion permeation primarily permits Na+ and K+ flux with variable Ca2+ permeability in certain subtypes, paralleling electrophysiological characterizations performed at Scripps Research and Karolinska Institutet. Desensitization kinetics and modal gating have been quantified using patch-clamp techniques refined at University of Cambridge and Imperial College London, while allosteric modulation principles derive from paradigms advanced at Roche and GlaxoSmithKline medicinal chemistry programs.

Physiological Roles

At the neuromuscular junction, muscle-type receptors mediate excitation-contraction coupling central to experiments historically conducted at Marine Biological Laboratory and Bell Labs-era physiology. Neuronal receptors regulate synaptic plasticity, attention, and reward circuits investigated in behavioral neuroscience centers such as Columbia University, University of California, Berkeley, and Duke University Medical Center. Roles in autonomic reflexes and sensory processing have been explored at National Institute on Drug Abuse and Institut du Cerveau et de la Moelle Épinière, while involvement in inflammatory modulation connects to translational work at Yale School of Medicine and University of Toronto. Dysfunctional signaling has implications in clinical phenotypes examined at Mount Sinai Hospital and Hospital for Sick Children.

Pharmacology and Modulators

Orthosteric agonists (nicotine, acetylcholine) and competitive antagonists (curare derivatives) were characterized in classical pharmacology programs at University of Chicago and Columbia-Presbyterian Medical Center. Partial agonists and smoking-cessation drugs developed by teams at Pfizer and GlaxoSmithKline illustrate translational impact, while allosteric modulators and positive allosteric modulators (PAMs) are subjects of research at Novartis and AstraZeneca. Neurotoxins such as α-bungarotoxin, first isolated in studies associated with Smithsonian Institution collections and biochemical labs at University of Oxford, remain critical tools for subtype identification. Drug screening platforms at European Molecular Biology Laboratory and high-throughput electrophysiology at Nanion Technologies have expanded ligand discovery, and clinical trials coordinated by National Institutes of Health consortia evaluate therapeutic potential in neurodegenerative and psychiatric disorders.

Genetic Variations and Disease Associations

Mutations in CHRNA and CHRNB family genes cause congenital myasthenic syndromes and are documented in case series from Johns Hopkins Hospital and genetic repositories curated by Broad Institute. Genome-wide association studies implicating loci near nAChR subunit genes have been reported by consortia including International HapMap Project and Wellcome Trust Case Control Consortium, linking variants to nicotine dependence, lung cancer susceptibility investigated by teams at Dana-Farber Cancer Institute and MD Anderson Cancer Center, and neuropsychiatric traits studied at National Institute of Mental Health. Pathogenic autoantibodies against muscle-type receptors define subsets of myasthenia gravis patients characterized in clinical centers such as Mayo Clinic and University College London Hospitals.

Experimental Methods and Models

Expression systems including Xenopus oocytes used by laboratories at Marine Biological Laboratory and mammalian cell lines employed in studies at Cold Spring Harbor Laboratory enable functional assays. Electrophysiological methods (patch-clamp, voltage-clamp) developed at Miller School of Medicine and imaging techniques (confocal, super-resolution) used at Max Planck Institute for Medical Research provide kinetic and localization data. Animal models ranging from Drosophila studies performed at University of California, San Diego to murine knockouts generated at Jackson Laboratory facilitate genetic and behavioral analyses. Structural determination using cryo-EM performed at Pacific Northwest National Laboratory and computational modeling pipelines at Lawrence Berkeley National Laboratory complement pharmacological screening at industry centers including GlaxoSmithKline and Pfizer.

Category:Neurotransmitter receptors